Application of Antigen Cross-Presentation Research into Patient Care

The activation of adaptive immune responses requires the processing and presentation of protein antigens to lymphocytes. Especially dendritic cells are effective at display of antigen-derived peptides in the form of immunogenic peptide/MHC complexes to CD4 and CD8-positive T cells, and can stimulate...

Full description

Saved in:
Bibliographic Details
Main Author: Marianne Boes (auth)
Format: Electronic Book Chapter
Language:English
Published: Frontiers Media SA 2017
Series:Frontiers Research Topics
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_41040
005 20210211
003 oapen
006 m o d
007 cr|mn|---annan
008 20210211s2017 xx |||||o ||| 0|eng d
020 |a 978-2-88945-191-3 
020 |a 9782889451913 
040 |a oapen  |c oapen 
024 7 |a 10.3389/978-2-88945-191-3  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Marianne Boes  |4 auth 
245 1 0 |a Application of Antigen Cross-Presentation Research into Patient Care 
260 |b Frontiers Media SA  |c 2017 
300 |a 1 electronic resource (124 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Frontiers Research Topics 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a The activation of adaptive immune responses requires the processing and presentation of protein antigens to lymphocytes. Especially dendritic cells are effective at display of antigen-derived peptides in the form of immunogenic peptide/MHC complexes to CD4 and CD8-positive T cells, and can stimulate even naive T cells to clonally expand. During the last 40 years, mechanisms that facilitate antigen processing and presentation were clarified, mostly from work in cell lines and mouse models. From mouse-based work, it is now clear that dendritic cells represent a collection of specialized cell subsets that are particularly well endowed to stimulate antigen transport to distinct tissue locations, to transfer antigens between cellular subsets or to trigger T cell responses. Dendritic cell subsets hold great promise for therapeutic application, for example as dendritic cell-based vaccines to bolster immune responses against viruses or malignant growths. Hurdles remain that preclude the efficient application of high quality pre-clinical research into standardized patient care. In this research topic, efforts in dendritic cell research and dendritic cell-based vaccines are discussed, from both pre-clinical and application points of view. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a clinical translation 
653 |a cross-presentation 
653 |a Vaccination 
653 |a Immunotherapy 
653 |a dendritic cell 
856 4 0 |a www.oapen.org  |u http://journal.frontiersin.org/researchtopic/1985/application-of-antigen-cross-presentation-research-into-patient-care  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/41040  |7 0  |z DOAB: description of the publication